No Data
Pacific Biosciences of California Full Year 2024 Earnings: EPS Beats Expectations
PacBio Grants Equity Incentive Award to New Employee
UBS Downgrades Pacific Biosciences of California(PACB.US) to Hold Rating, Cuts Target Price to $1.5
SoftBank Adds to Shares in VTEX, YMM, Cuts NMRA and Exits DASH, Among Other Moves
Bernstein Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $2
Pacific Biosciences of California Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Adjusted EPS Results. Also, Softbank Added 20.45M Shares in the Company.
Instrumental : Thanks for another no info tumblr post